Janke Kleynhans

6PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPlasma physics; fusion plasmas; electrical dischargesGene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Selective CXCR4-Targeting Radioconjugates Derived from LY2510924: Evaluation of [18F]AlF-NOTA-SC, [177Lu]Lu-BL02, and [161Tb]Tb-BL02 for Theranostic Development.

|Dec 30, 2025
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges.

Justine Maes, Bernard Pôlet, Janke Kleynhans

|Jan 08, 2025
Synthesis and characterisation of DOTA-kisspeptin-10 as a potential gallium-68/lutetium-177 pan-tumour radiopharmaceutical.

Janke Kleynhans, Robert Reeve, Cathryn H S Driver

|Apr 27, 2024
Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?

Janke Kleynhans, Thomas Ebenhan, Frederik Cleeren

|Feb 11, 2023
Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry.

Janke Kleynhans, Adriano Duatti, Cristina Bolzati

|Sep 01, 2020
Production of [68 Ga]Ga-PSMA: Comparing a manual kit-based method with a module-based automated synthesis approach.

Janke Kleynhans, Sietske Rubow, Jannie le Roux

Pageof 1

Frequent Collaborators

3 joint publications

Frederik Cleeren

2 joint publications

Thomas Ebenhan

2 joint publications

Christophe M Deroose

1 joint publications

Sietske Rubow